Valneva SE (VALN) Current Assets (2020 - 2026)

Valneva SE (VALN) posted quarterly Current Assets of $229.2 million for Q1 2026, down 29.82% year-on-year from $326.6 million in Q1 2025, and down 9.48% on a QoQ basis from $253.2 million in Q4 2025.

Valneva SE (VALN) Current Assets (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Current Assets for 7 consecutive years, with $229.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Current Assets fell 29.82% year-over-year to $229.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229.2 million (down 29.82% YoY) and the FY2025 annual result came in at $253.2 million, down 25.57% from the prior year.
  • Current Assets eased to $229.2 million in Q1 2026 per VALN's latest filing, from $253.2 million in the prior quarter.
  • Over the last five years, Current Assets for VALN reached as high as $620.2 million in Q1 2022 and fell as low as $229.2 million in Q1 2026.
  • A 5-year average of $382.0 million and a median of $345.5 million in 2024 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2023 — Current Assets plunged 38.11% — and 2024, when it climbed 13.77%.
  • Year by year, Current Assets stood at $483.2 million in 2022, then tumbled by 38.11% to $299.1 million in 2023, then grew by 13.77% to $340.3 million in 2024, then decreased by 25.57% to $253.2 million in 2025, then dropped by 9.48% to $229.2 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $229.2 million, $253.2 million, and $305.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 229.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 229.23 Mn
Dec 31, 2025 253.24 Mn
Sep 30, 2025 305.35 Mn
Jun 30, 2025 323.99 Mn
Mar 31, 2025 326.65 Mn
Dec 31, 2024 340.26 Mn
Sep 30, 2024 345.50 Mn
Jun 30, 2024 306.28 Mn
Mar 31, 2024 348.49 Mn
Dec 31, 2023 299.08 Mn
Sep 30, 2023 364.89 Mn
Jun 30, 2023 388.59 Mn
Mar 31, 2023 443.04 Mn
Dec 31, 2022 483.24 Mn
Sep 30, 2022 542.28 Mn
Jun 30, 2022 573.27 Mn
Mar 31, 2022 620.21 Mn
Dec 31, 2021 666.65 Mn
Dec 31, 2020 350.98 Mn